Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy?
about
Response biomarkers: re-envisioning the approach to tailoring drug therapy for cancerTranscriptome analysis reveals differentially expressed lncRNAs between oral squamous cell carcinoma and healthy oral mucosaMicroarray Expression Profiling of Long Non-Coding RNAs Involved in Nasopharyngeal Carcinoma Metastasis.The role of long non-coding RNAs in nasopharyngeal carcinoma: As systemic review.Biological role of long non-coding RNA in head and neck cancers.Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments.Circulating long noncoding RNAs as novel biomarkers of human diseases.Long noncoding RNAs in head and neck cancer.Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma.Roles of Long Noncoding RNAs in Recurrence and Metastasis of Radiotherapy-Resistant Cancer Stem Cells.Long non-coding RNA NEAT1 regulates epithelial membrane protein 2 expression to repress nasopharyngeal carcinoma migration and irradiation-resistance through miR-101-3p as a competing endogenous RNA mechanism.The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities.Serum, plasma and saliva biomarkers for head and neck cancer.LincRNA-p21 suppresses development of human prostate cancer through inhibition of PKM2.Current research on head and neck cancer-associated long noncoding RNAs.lncRNA in HNSCC: challenges and potential.Long non-coding RNA gastric carcinoma highly expressed transcript 1 promotes cell proliferation and invasion in human head and neck cancer.
P2860
Q28074295-1B24FE8C-4342-4A6D-811B-36E9AA135435Q33761812-F6036924-17D2-41A0-9E42-CA6E3C17EA2FQ37465789-7A0D13CF-E3BC-4A30-85F7-EE9F1014B716Q37716663-C2F3503F-B9B4-4449-9634-5FD8A0971CA1Q38631442-3086D815-4B35-47F4-A8A5-E07E82155523Q38737416-42F0FE15-A9E3-4B7C-B4CB-56FF0F028C8AQ38878172-603FF766-8F7B-4596-8EB4-00E09AADAF13Q38996024-A6FDD7BB-A008-4B0B-A591-487C81F081A6Q40228185-7935A411-8353-4DED-8808-14626553D451Q41660971-6D5F3E0C-07C2-4ED7-853E-FBCF54F2719EQ42378413-8AF725D7-3501-4CD3-8932-9C47F15DA37CQ47201290-A5044D10-016D-441F-8E24-9F697B57007DQ47405806-2B0D4EAC-6F18-4067-B66C-3B745AFDDBB7Q47673424-5F55B6A4-A77C-4E0B-A96B-4A1AA5E7E808Q49273546-273DFE6A-6A69-4CE8-89D5-C32A434AB854Q49708993-53815D7C-EAB4-4D1F-9708-B35A21783860Q54974134-A3949B98-1A78-474F-8941-5BACB7B85B5E
P2860
Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Do circulating long non-coding ...... reated with chemoradiotherapy?
@en
type
label
Do circulating long non-coding ...... reated with chemoradiotherapy?
@en
prefLabel
Do circulating long non-coding ...... reated with chemoradiotherapy?
@en
P2093
P2860
P1433
P1476
Do circulating long non-coding ...... reated with chemoradiotherapy?
@en
P2093
Dilek Sahin
Emre Ozgur
Gozde Ozkan
Husniye Isin
Makbule Tambas
Merdan Fayda
Murat Guveli
Musa Altun
Mustafa Isin
Rasim Meral
P2860
P2888
P304
P356
10.1007/S13277-015-4189-1
P577
2015-10-19T00:00:00Z
P5875
P6179
1018538764